BRITTNEY BOTH: Open Payments
NPI 1164093365 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 37 payments from 8 companies in 2025. Trend: 2023 $514 · 2024 $605 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $251 |
| E.R. Squibb & Sons, L.L.C. | 5 | $102 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| Alkermes, Inc. | 4 | $92 |
| Teva Pharmaceuticals USA, Inc. | 4 | $87 |
| ABBVIE INC. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
Products named: COBENFY, Auvelity, REXULTI, ARISTADA, ABILIFY MAINTENA, UZEDY, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across IA — which companies pay providers there.
